Study buoys Hubbard biotech company
HUBBARD — NanoLogix, a local biotechnology company, said an independent study shows that its testing methods for anthrax and bubonic plague are faster than conventional methods.
The research by Battelle Memorial Institute in Columbus was published in the current online issue of Letters in Applied Microbiology.
The authors found that NanoLogix technology displayed colonies of anthrax in six hours, compared with 24 hours with the fastest traditional methods.
The study also found that the NanoLogix technology allowed viewing of cultures of bubonic plague twice as fast as traditional petri-dish methods.
Bret Barnhizer, NanoLogix chief executive, said Monday he was elated by the results of the study and is looking forward to broader public awareness of the company’s technology.
The company has two testing methods that it says can be used on a wide variety of threats, including meningitis and salmonella.
NanoLogix has an office at 843 N. Main St. and has plans to bring production of test kits there. Now, limited production is being handled in Cincinnati, where research is conducted.
The company’s stock traded at 9 cents Monday, up 1 cent.